Table 2 Age range of eligibility for receiving vaccine and proportion of eligible children vaccinated during Vaccination Week of Americas, Bolivar, Venezuela, 2011
Vaccine | Age eligibility (months) | Minimum interval (after preceding dose), if applicable | No. eligible | No. (% of eligible) vaccinated [95% CI] | |
|---|---|---|---|---|---|
BCG | ≤12 | 18 | 16 | (89) | |
Hepatitis B | ≤1 | 13 | 11 | (85) | |
Pentavalent1* | ≥2 | 40 | 14 | (35) | |
Pentavalent2* | ≥4 | ≥28 days (Penta1) | 42 | 10 | (24) |
Pentavalent3* | ≥6 | ≥28 days (Penta2) | 60 | 14 | (23) |
OPV1 | ≥2 | 46 | 23 | (50) | |
OPV2 | ≥4 | ≥28 days (OPV1) | 52 | 18 | (35) |
OPV3 | ≥6 | ≥28 days (OPV2) | 74 | 15 | (20) |
MMR1 | ≥12 | 121 | 16 | (13) | |
Yellow fever | ≥12 | 127 | 3 | (2) | |
Rotavirus1 | 2 - 4 | 20 | 8 | (40) | |
Rotavirus2 | 4-8 | ≥28 days (Rotavirus1) | 11 | 6 | (55) |
Pentavalent4* (DTP boost1) | ≥18 | 155 | 14 | (9) | |
DTP boost2 | ≥60 | 9 | 5 | (56) | |
OPV boost1 | ≥18 | 138 | 17 | (12) | |
OPV boost2 | ≥60 | 45 | 1 | (2) | |
MMR2 | ≥60 | 87 | 4 | (5) | |
Any dose | ≤72 | 528 | 126 | (24) [20–28] | |
All indicated doses | ≤72 | 528 | 69 | (13) [10-16] | |